Education
About Us
Working with TipRanks
Follow Us
LFTD Partners (LIFD)
OTHER OTC:LIFD
Top Page
LFTD Partners
(OTC:LIFD)
Select Model
Select Model
Rating:50Neutral
Price Target:
$0.26
▼(-7.14% Downside)
LFTD Partners faces significant challenges in financial performance, particularly in profitability and cash flow management. The technical analysis indicates a neutral to slightly bearish trend, while the valuation suggests the stock is overvalued. These factors contribute to a cautious outlook for the stock.
Positive Factors
Stable Balance Sheet
A stable balance sheet with moderate leverage provides a solid foundation for the company to manage its financial obligations and invest in growth opportunities, supporting long-term stability.
Diversified Revenue Streams
Diversified revenue streams across different sectors reduce dependency on a single market, enhancing resilience against sector-specific downturns and supporting sustainable growth.
Solid Capital Structure
A healthy equity ratio reflects a strong capital structure, enabling the company to withstand economic fluctuations and invest in strategic initiatives for future growth.
Negative Factors
Declining Profitability
Negative profitability indicates challenges in cost management and revenue generation, which can hinder the company's ability to reinvest in its business and achieve long-term growth.
Cash Flow Challenges
Negative cash flow generation limits financial flexibility, constraining the company's ability to fund operations, pay down debt, and invest in growth, impacting long-term sustainability.
Inconsistent Revenue Growth
Inconsistent revenue growth undermines the company's ability to plan and invest strategically, potentially affecting its competitive position and long-term market share.
LFTD Partners (LIFD) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$4.15M
Dividend YieldN/A
Average Volume (3M)1.38K
Price to Earnings (P/E)75.7
Beta (1Y)0.40
Revenue Growth-12.70%
EPS GrowthN/A
CountryUS
Employees148
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)-0.02
Shares Outstanding14,822,678
10 Day Avg. Volume3,614
30 Day Avg. Volume1,380
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.19
Price to Sales (P/S)0.19
P/FCF Ratio-5.69
Enterprise Value/Market Cap1.38
Enterprise Value/Revenue0.15
Enterprise Value/Gross Profit0.49
Enterprise Value/Ebitda5.92
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
LFTD Partners Business Overview & Revenue Model
Company DescriptionLFTD Partners (LIFD) is a diversified holding company focused on acquiring and developing businesses in the cannabis, consumer products, and e-commerce sectors. The company is dedicated to fostering growth through innovative strategies and operational efficiencies. LIFD aims to capitalize on emerging market trends by leveraging its portfolio of brands and products that cater to evolving consumer preferences, particularly in wellness and lifestyle categories.
How the Company Makes MoneyLFTD Partners generates revenue primarily through its ownership and operation of various subsidiaries in the cannabis and consumer products sectors. The company earns money by selling products directly to consumers through e-commerce channels, as well as via wholesale distribution to retailers. Key revenue streams include sales from branded cannabis products, wellness items, and other consumer goods. Additionally, LIFD may engage in strategic partnerships with other businesses to enhance its market reach and product offerings, further contributing to its earnings. The company also focuses on optimizing operational efficiencies and cost management to maximize profit margins across its various business units.
LFTD Partners Earnings Call Summary
Earnings Call Date:Nov 14, 2024
(Q3-2024)
| % Change Since: |
Next Earnings Date:Nov 17, 2025
Earnings Call Sentiment Negative
The earnings call presented a mixed picture with notable efforts to launch new products and reduce expenses, but these were overshadowed by significant revenue declines, operating losses, and challenges in receivables. The competitive and regulatory environment continues to pose significant challenges to LFTD Partners.Q3-2024 Updates
Positive Updates
Launch of New Product Line
Launched the newest iteration of the flagship brand, Urb, featuring a Fly High theme with major initiatives to increase direct-to-retailer and direct-to-consumer online sales.
Expense Reduction Achievements
Reduced payroll expenses by 8% from Q1 '24 to Q2 '24 and another 8% from Q2 to Q3 '24. Professional fee expenses down 40% from Q1 to Q2 '24 and another 33% from Q2 to Q3.
Gross Margin Improvement
Excluding the effect of written-off inventory, gross margin as a percentage of net sales improved to 47% compared to 38%.
Negative Updates
Significant Revenue Decline
Consolidated net sales were $8.6 million, down 34% due to regulatory challenges, economic pressure on consumers, and increased competition.
Operating Loss
Reported an operating loss of $141,000 compared to operating income of $659,000 in the previous year.
Net Loss Reported
Net loss was $194,000 or $0.01 per share compared to net income of $617,000 or $0.04 per share.
Challenges in Receivables
Faced $864,000 of bad debt expense due to delayed payments from certain customers, impacting net receivables, net income, and earnings per share.
Company Guidance
During the LFTD Partners' Q3 2024 earnings call, several key metrics and strategic initiatives were discussed to address the current challenges and future prospects of the company. The company's consolidated net sales were reported at $8.6 million, a decline of 34% compared to the previous year, attributed to regulatory challenges and increased competition in the hemp-derived cannabinoid market. Despite these headwinds, the company has been proactive in reducing payroll expenses by 8% from Q1 to Q2 and another 8% from Q2 to Q3, along with a 40% reduction in professional fees from Q1 to Q2 and a further 33% reduction from Q2 to Q3. Furthermore, the company has reduced its CapEx from $747,000 in the previous year to $310,000 year-to-date. The operating loss for the quarter was $141,000, contrasting with an operating income of $659,000 in the same quarter of the previous year. The net loss was reported at $194,000 or $0.01 per share, compared to a net income of $617,000 or $0.04 per share in Q3 2023. The company's current ratio improved to 2.64, reflecting a focus on maintaining financial stability amidst industry challenges.LFTD Partners Financial Statement Overview
Summary
LFTD Partners exhibits a mixed financial performance with declining profitability and inconsistent revenue growth. The balance sheet remains stable with moderate leverage, but the company faces significant challenges in cash flow generation. Overall, the financial statements indicate areas of concern, particularly in profitability and cash flow management.Income Statement
LFTD Partners has experienced significant volatility in its revenue growth, with a notable decline in recent years. The gross profit margin has decreased over time, indicating potential cost management issues. The net profit margin is negative in the latest TTM period, reflecting challenges in achieving profitability. Overall, the income statement shows a mixed performance with declining profitability and inconsistent revenue growth.45
Neutral
Balance Sheet
The company's balance sheet reflects a stable debt-to-equity ratio, indicating moderate leverage. However, the return on equity has significantly decreased, suggesting reduced efficiency in generating returns for shareholders. The equity ratio remains healthy, indicating a solid capital structure. Overall, the balance sheet is stable but shows reduced profitability.65
Positive
Cash Flow
LFTD Partners faces challenges in cash flow generation, with negative operating and free cash flows in the latest TTM period. The free cash flow growth rate is negative, indicating declining cash generation capabilities. The operating cash flow to net income ratio is also negative, highlighting inefficiencies in converting income into cash. Overall, the cash flow statement reflects significant cash management challenges.40
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.99M | 37.33M | 51.61M | 57.42M | 31.66M | 5.34M |
| Gross Profit | 11.68M | 12.75M | 19.70M | 20.99M | 15.94M | 1.94M |
| EBITDA | 964.48K | -1.50M | 3.35M | 10.31M | 7.40M | -1.45M |
| Net Income | 60.05K | -1.86M | 2.16M | 7.20M | 5.80M | -1.53M |
Balance Sheet | ||||||
| Total Assets | 44.94M | 47.32M | 51.35M | 41.13M | 39.42M | 27.83M |
| Cash, Cash Equivalents and Short-Term Investments | 1.92M | 2.15M | 4.36M | 3.72M | 1.60M | 439.08K |
| Total Debt | 3.33M | 4.51M | 4.49M | 1.86M | 1.34M | 3.91M |
| Total Liabilities | 7.39M | 9.81M | 12.53M | 6.59M | 11.96M | 6.21M |
| Stockholders Equity | 37.56M | 37.50M | 38.82M | 34.54M | 27.46M | 21.62M |
Cash Flow | ||||||
| Free Cash Flow | -197.81K | -1.27M | -150.74K | 2.12M | 5.25M | -408.17K |
| Operating Cash Flow | -107.72K | -960.07K | 638.92K | 3.04M | 5.62M | -338.04K |
| Investing Cash Flow | -86.05K | -479.57K | -2.52M | -916.12K | -446.65K | -3.51M |
| Financing Cash Flow | -1.06M | -770.95K | 3.70M | -193.42K | -4.01M | -98.00K |
LFTD Partners Technical Analysis
Positive
0.28
Price Trends
0.26
Positive
0.27
Positive
0.31
Negative
Market Momentum
<0.01
Negative
53.31
Neutral
72.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LIFD, the sentiment is Positive. The current price of 0.28 is above the 20-day moving average (MA) of 0.25, above the 50-day MA of 0.26, and below the 200-day MA of 0.31, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 53.31 is Neutral, neither overbought nor oversold. The STOCH value of 72.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for LIFD.
LFTD Partners Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | $4.15M | 75.68 | -2.05% | ― | -12.70% | ― | |
46 Neutral | $5.64M | -0.22 | -37.38% | ― | -22.60% | 53.82% | |
45 Neutral | $7.92M | -1.87 | -93.87% | ― | -0.74% | 81.49% | |
40 Underperform | $12.22M | -0.42 | -44.42% | ― | -1.50% | 80.17% | |
39 Underperform | $153.27M | -0.37 | -114.52% | ― | -86.05% | 24.17% |
* Healthcare Sector Average
LIFD
LFTD Partners
0.28
-0.21
-42.86%
YCBD
cbdMD
1.66
-1.23
-42.56%
IMCC
IM Cannabis Corp
1.47
-0.92
-38.49%
FLGC
Flora Growth
7.26
-36.03
-83.23%
IXHL
Incannex Healthcare Limited Sponsored ADR
0.40
-1.40
-77.78%
AKAN
Akanda Corp
0.56
-4.25
-88.36%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.